Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Other Non Operating Income: 2023-2024

Historic Other Non Operating Income for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $8.2 million.

  • Zenas BioPharma's Other Non Operating Income fell 54.54% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 100.02%. This contributed to the annual value of $8.2 million for FY2024, which is 1210.10% up from last year.
  • As of FY2024, Zenas BioPharma's Other Non Operating Income stood at $8.2 million, which was up 1,210.10% from $624,000 recorded in FY2023.
  • Zenas BioPharma's 5-year Other Non Operating Income high stood at $8.2 million for FY2024, and its period low was $624,000 during FY2023.
  • Its 2-year average for Other Non Operating Income is $4.4 million, with a median of $4.4 million in 2023.
  • Data for Zenas BioPharma's Other Non Operating Income shows a peak YoY skyrocketed of 1,210.10% (in 2024) over the last 5 years.
  • Zenas BioPharma's Other Non Operating Income (Yearly) stood at $624,000 in 2023, then spiked by 1,210.10% to $8.2 million in 2024.